✉ Email this page to a colleague
« Back to Dashboard
N,N-Dimethyltryptamine is an investigational drug.
There have been 11 clinical trials for N,N-Dimethyltryptamine. The most recent clinical trial was a Phase 2 trial, which was initiated on April 1st 2007.
The most common disease conditions in clinical trials are Depression, Depressive Disorder, and Anxiety Disorders. The leading clinical trial sponsors are Johns Hopkins University, Heffter Research Institute, and Joshua Woolley, MD/PhD.
Recent Clinical Trials for N,N-Dimethyltryptamine
|Acute Dose-dependent Effects of DMT in Healthy Subjects: A Placebo-controlled Cross-over Study||University Hospital, Basel, Switzerland||Phase 1|
|Psilocybin Therapy for Chronic Low Back Pain||Joshua Woolley, MD/PhD||Phase 1/Phase 2|
|Effects of Psilocybin on Electrophysiology and the Dynamic Content of Thought||Johns Hopkins University||Phase 1/Phase 2|